Contrave Diet Drug Approved by FDA
Sept. 10, 2014 — The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The drug is approved for use in adults with a body mass index of 30 or greater (obesity) or […]
Contrave Diet Drug Approved by FDA Read More »